Asset
ROXADUSTAT
Revenue
No revenue reported in loaded filings.
Clinical trials (6)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03303066 | phase2_3 | completed | 2018-06-06 | 2023-01-11 | Kyntra Bio | Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS) |
| NCT02652806 | phase3 | completed | 2015-12-01 | 2017-01-24 | Kyntra Bio | FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease |
| NCT02652819 | phase3 | completed | 2015-12-01 | 2017-01-24 | Kyntra Bio | FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis |
| NCT01599507 | phase2 | completed | 2011-12-01 | 2013-01-01 | Kyntra Bio | Study of FG-4592 in Subjects With Chronic Kidney Disease in China |
| NCT01596855 | phase2 | completed | 2011-09-01 | 2013-01-01 | Kyntra Bio | Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China |
FDA applications (0)
This company has no applications containing this asset.